
Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Late-stage product finance investor in biopharmaceutical products, with animal health partnerships

Novaquest Capital Management invests in late-stage biopharmaceutical products through a model it calls product finance. It also forms partnerships with animal health companies. Its financing deals have supported drug developers without issuing new shares in some cases.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Novaquest Capital Management.
Similar listings buyers compare against this one.

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Venture capital firm partnering with founders from first idea through to public listing

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications

Venture capital firm with a portfolio spanning tutoring, healthcare, recruiting, trucking safety, policing and sports software

Baltimore foundation that funds research and commissions reports on public issues affecting the city and Maryland

Vienna investment fund providing revenue-based financing to European software and technology growth companies

Venture capital firm backing technology-enabled companies in Latin America that want to scale globally

Pre-seed fund and accelerator backing startups that build resilience for underserved, climate-vulnerable communities
Everything here links back to the same verified catalogue. Pick your next stop.